Table 1.
Vehicle |
Ranitidine |
|||
---|---|---|---|---|
Mean | SE | Mean | SE | |
Total body weight, g | 355 | 7.3 | 364 | 8.1 |
Two kidneys-to-body weight ratio, mg/g | 9.8 | 0.35 | 9.7 | 0.27 |
Heart weight-to-body weight ratio, mg/g | 3.8 | 0.12 | 3.8 | 0.09 |
Plasma Na+, mM | 145 | 0.51 | 146 | 0.36 |
Plasma K+, mM | 3.2 | 0.08 | 3.4 | 0.08 |
Plasma Cl−, mM | 106 | 0.59 | 107 | 0.57 |
Glomerular filtration rate, mL/min/100 g) | 0.8 | 0.07 | 0.8 | 0.07 |
n = 7–8 for vehicle treatment and 10 for ranitidine treatment. The following parameters were assessed: total body weight, two kidneys-to-body weight ratio, heart weight-to-body weight ratio, plasma Na+, plasma K+, and plasma Cl−. As a measure of renal function for high-salt diet-fed Dahl salt-sensitive rats for vehicle vs. ranitidine treatment, glomerular filtration rate was assessed as the filtration rate of FITC-inulin.